The amount is only half of that proposed by the company’s managers in May.
Antibiotice will use the other half to pay out dividends to its shareholders. The company will pay a gross dividend of RON0.036 a share, well above RON0.015 a share distributed last year.
Still on Thursday, the pharmaceuticals company approved taking out a RON60 million loan from EximBank to refinance an older credit line and finance operations.
Antibiotice reported a 57.6% drop in its first quarter net profit to RON5.5 million, hurt by lower sales on the local market.
The company is majority-owned by Romania’s Health Ministry, with a 53% stake, while investment fund SIF Oltenia (SIF5.RO) holds a 10% stake.
At around 3:55 pm, Antibiotice’s shares traded down 1.67% at RON0.47 in Bucharest, amid a rising market. (EUR1=RON4.4463)